Skip to main content
Xbrane Biopharma logo

Xbrane Biopharma — Investor Relations & Filings

Ticker · XBRANE ISIN · SE0007789409 LEI · 5493008DKD05APTKQO39 ST Manufacturing
Open in API
Filings indexed 359 across all filing types
Latest filing 2023-12-20 AGM Information
Country SE Sweden
Listing ST XBRANE

About Xbrane Biopharma

https://xbrane.com/en/

Xbrane Biopharma is a biotechnology company that specializes in the development of biosimilars—follow-on versions of approved biological drugs. The company's mission is to enhance the accessibility of biological treatments for serious diseases by creating more affordable alternatives. Xbrane utilizes a patented platform technology and efficient manufacturing systems, employing both bacterial and mammalian cells, to achieve lower production costs. Its development pipeline includes several biosimilar candidates, with a key product being a ranibizumab biosimilar.

Recent filings

Filing Released Lang Actions
XBRANE BIOPHARMA ANNOUNCES NOMINATION COMMITTEE CHANGES
AGM Information Classification · 98% confidence The document is titled "XBRANE BIOPHARMA ANNOUNCES NOMINATION COMMITTEE CHANGES" and details the composition and changes within the Nomination Committee, which is responsible for preparing proposals for the Annual General Meeting (AGM) regarding board members and remuneration. This content directly relates to the governance structure and the process leading up to the AGM. While it mentions the AGM date (May 2nd, 2024), the core subject is the committee structure itself, which falls under Governance Information (CGR). It is not a formal AGM presentation (AGM-R), a proxy statement (PSI), or a general management announcement (MANG), but rather a specific disclosure about a governance body's composition. Given the focus on committee structure and governance principles, CGR is the most appropriate fit.
2023-12-20 English
XBRANE BIOPHARMA MEDDELAR FÖRÄNDRING AV VALBEREDNING
Board/Management Information Classification · 99% confidence The document text is titled "XBRANE BIOPHARMA MEDDELAR FÖRÄNDRING AV VALBEREDNING" (Xbrane Biopharma Announces Change in the Nomination Committee). It details the composition changes, appointments, and responsibilities of the company's Nomination Committee (Valberedning) ahead of the Annual General Meeting (AGM) in May 2024. This content directly relates to the governance structure and the process for nominating board members and auditors, which falls under Board/Management Information or Governance Information. Since the core subject is the composition and changes within the body responsible for nominating directors, it aligns most closely with Board/Management Information (MANG), which covers changes in senior company bodies, or Governance Information (CGR). Given the specific focus on the 'Valberedning' (Nomination Committee) composition and its role in preparing proposals for the AGM, MANG is a strong fit, as it often encompasses changes to key governance bodies. However, CGR (Governance Information) is also highly relevant. Since the document announces a change in the composition of a key governance body (the Nomination Committee), MANG (Board/Management Information) is selected as the most specific fit for announcing changes to these high-level internal structures, although CGR is a close second. The document is a formal announcement, not a presentation (AGM-R) or a full report (10-K/IR).
2023-12-20 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage, specifically noting the 'Reason for major shareholding notification' and providing exact figures for shares held before and after a transaction, along with the resulting percentage (5.13057%). This structure is characteristic of a notification regarding significant changes in ownership thresholds. The filing explicitly mentions 'Resulting distribution of total holdings' and 'Group total holdings' related to voting rights and shares. This aligns directly with the definition of a Major Shareholding Notification (MRQ). The document length is short (3945 chars), but the content is the notification itself, not an announcement of a report.
2023-12-13 English
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by Avanza Bank Holding AB for its subsidiary, specifically noting the 'Reason for major shareholding notification' and providing exact share quantities and resulting percentages (4.96736% directly held, 5.45149% total voting rights). This structure, focusing on crossing a threshold (5%) and reporting the resulting ownership, is characteristic of a Major Shareholding Notification. The filing type code corresponding to this is MRQ (Major Shareholding Notification). The document length is short (3691 chars), but it is the primary report itself, not an announcement of a report, so RPA/RNS is not the primary classification.
2023-12-11 English
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 98% confidence The document details a transaction involving a change in shareholding percentage by a holder ('Nordnet AB (publ)') in the issuer ('Xbrane Biopharma AB'). Key phrases include 'Reason for major shareholding notification Sell', 'Shares', 'Voting rights', and the resulting 'Percentage' of ownership after the transaction. This structure is characteristic of a notification regarding a significant change in ownership, which corresponds to the Major Shareholding Notification category.
2023-12-08 English
Major Shareholding Notification 2023
Major Shareholding Notification Classification · 100% confidence The document is a regulatory filing from the Swedish Financial Supervisory Authority (Finansinspektionen) regarding a 'flaggningsmeddelande' (flagging notification). It details a change in shareholding by Serendipity Group AB in Xbrane Biopharma AB, specifically reporting the sale of shares that crossed a 5% threshold. This fits the definition of a Major Shareholding Notification (MRQ).
2023-12-08 Swedish

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.